CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-02 | Gordon David N. Chief Medical Officer | Shares withheld for taxes | −2,280 | $23.25 | $53K | 108,492 |
| 2021-03-02 | Gordon David N. Chief Medical Officer | Option exercise · Restricted stock units | −8,297 | 24,892 | ||
| 2021-03-02 | Ali-Jackson Kamil Chief Legal Officer | Option exercise | +6,637 | 145,524 | ||
| 2021-03-02 | Ali-Jackson Kamil Chief Legal Officer | Shares withheld for taxes | −1,906 | $23.25 | $44K | 143,618 |
| 2021-03-02 | Ali-Jackson Kamil Chief Legal Officer | Option exercise · Restricted stock units | −6,637 | 19,914 | ||
| 2021-03-02 | Ruffo Frank Chief Financial Officer | Option exercise | +8,297 | 241,903 | ||
| 2021-03-02 | Ruffo Frank Chief Financial Officer | Shares withheld for taxes | −2,844 | $23.25 | $66K | 239,059 |
| 2021-03-02 | Ruffo Frank Chief Financial Officer | Option exercise · Restricted stock units | −8,297 | 24,892 | ||
| 2021-03-02 | Walker Neal President and CEO | Option exercise | +18,253 | 1,230,409 | ||
| 2021-03-02 | Walker Neal President and CEO | Shares withheld for taxes | −7,982 | $23.25 | $186K | 1,222,427 |
| 2021-03-02 | Walker Neal President and CEO | Option exercise · Restricted stock units | −18,253 | 54,762 | ||
| 2021-03-01 | Gordon David N. Chief Medical Officer | Option exercise | +20,600 | 108,135 | ||
| 2021-03-01 | Gordon David N. Chief Medical Officer | Shares withheld for taxes | −5,660 | $24.06 | $136K | 102,475 |
| 2021-03-01 | Gordon David N. Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +99,500 | 99,500 | ||
| 2021-03-01 | Gordon David N. Chief Medical Officer | Grant or award · Restricted stock units | +28,400 | 28,400 | ||
| 2021-03-01 | Gordon David N. Chief Medical Officer | Option exercise · Restricted stock units | −20,600 | 41,200 | ||
| 2021-03-01 | Ali-Jackson Kamil Chief Legal Officer | Option exercise | +17,175 | 143,821 | ||
| 2021-03-01 | Ali-Jackson Kamil Chief Legal Officer | Shares withheld for taxes | −4,934 | $24.06 | $119K | 138,887 |
| 2021-03-01 | Ali-Jackson Kamil Chief Legal Officer | Grant or award · Employee Stock Option (Right to Buy) | +99,500 | 99,500 | ||
| 2021-03-01 | Ali-Jackson Kamil Chief Legal Officer | Grant or award · Restricted stock units | +28,400 | 28,400 |
Page 32 of 34 · 680 trades